Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics

Faure, Grazyna; Gowda, Veerabasappa T.; Maroun, Rachid C.
January 2007
BMC Structural Biology;2007, Vol. 7, p82
Academic Journal
Background: The snake venom group IIA secreted phospholipases A2 (SVPLA2), present in the Viperidae snake family exhibit a wide range of toxic and pharmacological effects. They exert their different functions by catalyzing the hydrolysis of phospholipids (PL) at the membrane/water interface and by highly specific direct binding to: (i) presynaptic membrane-bound or intracellular receptors; (ii) natural PLA2-inhibitors from snake serum; and (iii) coagulation factors present in human blood. Results: Using surface plasmon resonance (SPR) protein-protein interaction measurements and an in vitro biological test of inhibition of prothrombinase activity, we identify a number of Viperidae venom SVPLA2s that inhibit blood coagulation through direct binding to human blood coagulation factor Xa (FXa) via a non-catalytic, PL-independent mechanism. We classify the SVPLA2s in four groups, depending on the strength of their binding. Molecular electrostatic potentials calculated at the surface of 3D homology-modeling models show a correlation with inhibition of prothrombinase activity. In addition, molecular docking simulations between SVPLA2 and FXa guided by the experimental data identify the potential FXa binding site on the SVPLA2s. This site is composed of the following regions: helices A and B, the Ca2+ loop, the helix C-β-wing loop, and the C-terminal fragment. Some of the SVPLA2 binding site residues belong also to the interfacial binding site (IBS). The interface in FXa involves both, the light and heavy chains. Conclusion: We have experimentally identified several strong FXa-binding SVPLA2s that disrupt the function of the coagulation cascade by interacting with FXa by the non-catalytic PL-independent mechanism. By theoretical methods we mapped the interaction sites on both, the SVPLA2s and FXa. Our findings may lead to the design of novel, non-competitive FXa inhibitors.


Related Articles

  • Structural and Functional Characterization of Anticoagulant, FXa-binding Viperidae Snake Venom Phospholipases A2. Faure, Grazyna; Saul, Frederick // Acta Chimica Slovenica;2011, Vol. 58 Issue 4, p671 

    Certain snake venom phospholipases A2 (PLA2) have been identified as specific, non-competitive blood coagulation inhibitors that bind with high affinity to human activated blood coagulation factor X (hFXa). Recent determination of the three-dimensional structures of PLA2 isoforms which differ in...

  • Structural and Functional Characterization of a γ-Type Phospholipase A2 Inhibitor from Bothrops jararacussu Snake Plasma. Oliveira, Clayton Z.; Santos-Filho, Norival A.; Menaldo, Danilo L.; Boldrini-França, Johara; Giglio, José R.; Calderon, Leonardo A.; Stábeli, Rodrigo G.; Rodrigues, Fabio H. S.; Tasic, Ljubica; da Silva, Saulo L.; Soares, Andreimar M. // Current Topics in Medicinal Chemistry;Oct2011, Vol. 11 Issue 20, p2509 

    Phospholipases A2 (PLA2s) from snake venoms comprise a group of 14-18 kDa proteins, responsible for several toxic effects induced by the whole venom. Considering this, studies aiming at the search for natural inhibitors of these proteins are very important. The present work had as objectives the...

  • Pharmacological perspectives of snake venoms from Viperidae family. Paulchamy, Chellapandi // Internet Journal of Pharmacology;2010, Vol. 8 Issue 2, p9 

    Snake venom is a combination of many different proteins and enzymes. Many of these proteins are harmless to humans, but some are toxins. Snake venoms effects include pro- and anti-blood coagulation, neurotoxicity, mycotoxicity, nephrotoxicity, cardiotoxicity and necrotoxicity. This article has...

  • Aptamer RA36 Inhibits of Human, Rabbit, and Rat Plasma Coagulation Activated with Thrombin or Snake Venom Coagulases. Savchik, E. Yu.; Kalinina, T. B.; Drozd, N. N.; Makarov, V. A.; Zav’yalova, E. G.; Lapsheva, E. N.; Mudrik, N. N.; Babij, A. V.; Pavlova, G. V.; Golovin, A. V.; Kopylov, A. M. // Bulletin of Experimental Biology & Medicine;Nov2013, Vol. 156 Issue 1, p44 

    RA36 DNA aptamer is a direct anticoagulant prolonging clotting time of human, rabbit, and rat plasma in the thrombin time test. Anticoagulant activity of RA36 is lower than that of recombinant hirudin. During inhibition of human plasma clotting activated with echitox (coagulase from Echis...

  • Assesment of Coagulopathy in Patients with Systemic Bleeding due to Snake Bite -- Correlation with the Dose of Anti Snake Venom. Suresh, Vaddadi; Bhargavi, E. Usha; Guptha, N. S. R. C.; Ramana Murthy, S. V. // Indian Journal of Public Health Research & Development;Oct-Dec2015, Vol. 6 Issue 4, p324 

    Background: Even though snakebite associated coagulopathy is a common cause of mortality and morbidity in India, the severity assessment and management protocols are poorly defined. Our study aims at identifying - a) Clinical spectrum of bleeding B) Hematological markers of severe coagulopathy...

  • Snake venom inspires coagulant gel.  // Engineer (Online Edition);10/27/2015, p3 

    The article reviews research led by Rice University researchers Jeffrey Hartgerink and Vivek Kumar, published in an issue of the "ACS Biomaterials Science and Engineering" journal, that combines a derivative of snake venom with their nanofibre hydrogel to help encourage blood clotting. Topics...

  • Snake venom may prevent. Investor's Business Daily // Investors Business Daily;11/17/2015, pA02 

    The article reports on the study conducted by Rice University in Texas and funded by the U.S. National Institute of Health and nonprofit organization Welch Foundation, which suggests that snake venom combined with nanofibers on rats may prevent blood clots during surgery.

  • Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2. Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He // BMC Immunology;2009, Vol. 10, Special section p1 

    Background: It has been recognized that phospholipase A2 (PLA2) is a crucial component of snake venom, which contributes greatly to snake venom induced inflammation in man. However, the mechanisms through which N49 PLA2 provoke inflammation remain unclear. Recently, a N49 PLA2, TM-N49 from...

  • Molecular Cloning and Pharmacological Properties of an Acidic PLA2 from Bothrops pauloensis Snake Venom. Ferreira, Francis Barbosa; Gomes, Mário Sérgio Rocha; de Souza, Dayane Lorena Naves; Gimenes, Sarah Natalie Cirilo; Castanheira, Letícia Eulalio; Borges, Márcia Helena; Rodrigues, Renata Santos; Yoneyama, Kelly Aparecida Geraldo; Brandeburgo, Maria Inês Homsi; Rodrigues, Veridiana M. // Toxins;Dec2013, Vol. 5 Issue 12, p2403 

    In this work, we describe the molecular cloning and pharmacological properties of an acidic phospholipase A2 (PLA2) isolated from Bothrops pauloensis snake venom. This enzyme, denominated BpPLA2-TXI, was purified by four chromatographic steps and represents 2.4% of the total snake venom protein...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics